4.6 Article

Efficacy and Safety of Romosozumab Among Postmenopausal Women With Osteoporosis and Mild-to-Moderate Chronic Kidney Disease

Related references

Note: Only part of the references are listed.
Article Endocrinology & Metabolism

Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Guideline Update

Dolores Shoback et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)

Article Endocrinology & Metabolism

Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline

Richard Eastell et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)

Article Medicine, General & Internal

Abaloparatide in patients with mild or moderate renal impairment: results from the ACTIVE phase 3 trial

John P. Bilezikian et al.

CURRENT MEDICAL RESEARCH AND OPINION (2019)

Review Urology & Nephrology

Management of Osteoporosis in CKD

Pascale Khairallah et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)

Review Medicine, General & Internal

Management of Osteoporosis in Chronic Kidney Disease

Kosaku Nitta et al.

INTERNAL MEDICINE (2017)

Article Urology & Nephrology

Osteoporosis, bone mineral density and CKD-MBD: treatment considerations

Jordi Bover et al.

JOURNAL OF NEPHROLOGY (2017)

Article Medicine, General & Internal

Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis

Kenneth G. Saag et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Chemistry, Medicinal

Profile of romosozumab and its potential in the management of osteoporosis

Sian Yik Lim et al.

DRUG DESIGN DEVELOPMENT AND THERAPY (2017)

Article Medicine, General & Internal

Romosozumab Treatment in Postmenopausal Women with Osteoporosis

F. Cosman et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Article Geriatrics & Gerontology

Public Health Impact of Osteoporosis

Jane A. Cauley

JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2013)

Article Endocrinology & Metabolism

A single-dose study of denosumab in patients with various degrees of renal impairment

Geoffrey A. Block et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2012)

Article Urology & Nephrology

The Clinician and Estimation of Glomerular Filtration Rate by Creatinine-based Formulas: Current Limitations and Quo Vadis

Rossini Botev et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)

Article Endocrinology & Metabolism

Effects of Denosumab on Fracture and Bone Mineral Density by Level of Kidney Function

Sophie A. Jamal et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2011)

Review Medicine, General & Internal

Fragility fractures in chronic kidney disease: An opinion-based approach

Paul D. Miller

CLEVELAND CLINIC JOURNAL OF MEDICINE (2009)

Article Medicine, General & Internal

Mortality Risk Associated With Low-Trauma Osteoporotic Fracture and Subsequent Fracture in Men and Women

Dana Bliuc et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)

Article Urology & Nephrology

Combining GFR and Albuminuria to Classify CKD Improves Prediction of ESRD

Stein I. Hallan et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)

Article Endocrinology & Metabolism

Alendronate treatment in women with normal to severely impaired renal function: An analysis of the fracture intervention trial

Sophie A. Jamal et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2007)

Article Endocrinology & Metabolism

Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment

P. D. Miller et al.

OSTEOPOROSIS INTERNATIONAL (2007)

Article Urology & Nephrology

Relationship between moderate to severe kidney disease and hip fracture in the United States

Thomas L. Nickolas et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)

Article Endocrinology & Metabolism

Relationship between age, renal function and bone mineral density in the US population

S Klawansky et al.

OSTEOPOROSIS INTERNATIONAL (2003)